Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
149M
-
Number of holders
-
406
-
Total 13F shares, excl. options
-
138M
-
Shares change
-
+12M
-
Total reported value, excl. options
-
$1.87B
-
Value change
-
+$143M
-
Put/Call ratio
-
1.12
-
Number of buys
-
183
-
Number of sells
-
-181
-
Price
-
$13.53
Significant Holders of Chemours Co - Common Stock, par value $0.01 per share (CC) as of Q1 2025
511 filings reported holding CC - Chemours Co - Common Stock, par value $0.01 per share as of Q1 2025.
Chemours Co - Common Stock, par value $0.01 per share (CC) has 406 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138M shares
of 149M outstanding shares and own 92.9% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (21.7M shares), VANGUARD GROUP INC (16.5M shares), FMR LLC (15.9M shares), MARSHALL WACE, LLP (5.96M shares), JPMORGAN CHASE & CO (5.52M shares), STATE STREET CORP (4.98M shares), MILLENNIUM MANAGEMENT LLC (4.02M shares), UBS Group AG (3.72M shares), AMERIPRISE FINANCIAL INC (3.47M shares), and Appian Way Asset Management LP (2.47M shares).
This table shows the top 406 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.